Head Of Research And Development
CurrentDeveloping innovative antibacterial biologicals.
Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Michael Plank is listed as Head of Research And Development at MEDEA Biopharma, based in Regenstauf, Bavaria, Germany. AeroLeads shows a matched LinkedIn profile for Michael Plank.
Michael Plank previously worked as Lecturer: Microbiology and Immunology at Berufsbildungszentrum Augsburg & Schwaben and Postdoctoral Researcher at Dkfz German Cancer Research Center. Michael Plank holds Doctor Of Philosophy (Phd), Systems Biology from University Of Oxford.
This section adds company-level context without repeating Michael Plank's masked contact details.
Review company-level records connected to Michael Plank before choosing the right outreach path.
As a PostDoc at the University of Geneva and University of Arizona, I have been conducting cutting-edge research in the areas of Proteomics, Systems Biology and Network Analysis of cell signaling. I have more than ten years of experience in applying computational and experimental methods to study complex biological systems and their dynamics.I am experienced in experimental design, statistics and mentoring junior researchers, and and I have obtained multiple certifications in data analysis and teaching. I have also published several peer-reviewed papers, demonstrating my ability to communicate and disseminate scientific findings.I bring a passion for research, rigor and creativity of a scientist and an analytical, data-driven mindset.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Ludwigshafen, Rhineland-Palatinate, Germany
Developing innovative antibacterial biologicals.
Heidelberg, Baden-Württemberg, Germany
Analysis of Extracellular Matrix composition in fibrosis
Tucson
PKA and TOR signaling dynamics:-Submitted: Plank M., Carmiol N., Mitri B., and Capaldi A. P. Systems level analysis of time and stimuli specific signaling through PKA (bioRxiv 2022.03.10.483795)-Review: Plank, M. Interaction of TOR and PKA Signaling in S. Cerevisiae. Biomolecules 2022; 12 (2): 210-Funding: BIO5 PostDoctoral Fellowship-Peer review: cells; International Journal of Molecular SciencesSignaling network inference:-Submitted: Plank M. Network inference from… Show more PKA and TOR signaling dynamics:-Submitted: Plank M., Carmiol N., Mitri B., and Capaldi A. P. Systems level analysis of time and stimuli specific signaling through PKA (bioRxiv 2022.03.10.483795)-Review: Plank, M. Interaction of TOR and PKA Signaling in S. Cerevisiae. Biomolecules 2022; 12 (2): 210-Funding: BIO5 PostDoctoral Fellowship-Peer review: cells; International Journal of Molecular SciencesSignaling network inference:-Submitted: Plank M. Network inference from temporal phosphoproteomics informed by protein-protein interactions (bioRxiv 2023.04.26.538385)Proteomics:-Review: Plank M. Modern Data Acquisition Approaches in Proteomics Based on Dynamic Instrument Control. J. Proteome Res. (2022)-Funding: Core Facilities Pilot Program Grant-Guest editor: Journal of Video Experiments (JoVE)Teaching and mentoring:-Co-teaching: Introduction to Systems Biology'Teaching certificates: Evidence-based STEM-Teaching; Turning your Research into Teaching; First-year Faculty Teaching Academy Show less
Geneva
Growth regulatory cell signaling networks:-Published: Plank M., et al. Chemical Genetics of AGC-kinases Reveals Shared Targets of Ypk1, Protein Kinase A and Sch9. Mol Cell Proteomics (2020)-Published: Plank M., Berti M., Loewith R. Phosphoproteomic Effects of Acute Depletion of PP2A Regulatory Subunit Cdc55. Proteomics (2020)Proteomics:-Co-author: Serbyn N. et al. Mol Cell. (2020)-Co-author: Liu W. et al. ACS Central Science (2021) Workshop organizer and… Show more Growth regulatory cell signaling networks:-Published: Plank M., et al. Chemical Genetics of AGC-kinases Reveals Shared Targets of Ypk1, Protein Kinase A and Sch9. Mol Cell Proteomics (2020)-Published: Plank M., Berti M., Loewith R. Phosphoproteomic Effects of Acute Depletion of PP2A Regulatory Subunit Cdc55. Proteomics (2020)Proteomics:-Co-author: Serbyn N. et al. Mol Cell. (2020)-Co-author: Liu W. et al. ACS Central Science (2021) Workshop organizer and instructor: Mass spectrometry-based proteomics (2019)Presentations:-National Center of Competence in Research (NCCR) retreats, Villars-sur-Ollon, 2017, 2018 and 2019-University of Geneva PostDoc day, 2019-FASEB Conference: “Protein Phosphatases”, Snowmass, 2018-SNF site visit, Geneva, 2017Member of selection committee Prix Arditi for best Ph.D. thesis, 2019 Show less
Quick answers generated from the profile data available on this page.
Michael Plank works for MEDEA Biopharma.
Michael Plank is listed as Head of Research And Development at MEDEA Biopharma.
Michael Plank is based in Regenstauf, Bavaria, Germany while working with MEDEA Biopharma.
Michael Plank has worked for Medea Biopharma, Berufsbildungszentrum Augsburg & Schwaben, Dkfz German Cancer Research Center, University Of Arizona, and University Of Geneva.
You can use AeroLeads to view verified contact signals for Michael Plank at MEDEA Biopharma, including work email, phone, and LinkedIn data when available.
Michael Plank holds Doctor Of Philosophy (Phd), Systems Biology from University Of Oxford.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Michael Plank you were looking for.